Cargando…
Development and acceptability of a decision aid for anxiety disorder considering discontinuation of benzodiazepine anxiolytic
AIM: We aimed to develop a decision aid (DA) for individuals with anxiety disorders who consider tapering benzodiazepine (BZD) anxiolytics, and if tapering, tapering BZD anxiolytics with or without cognitive behavioral therapy (CBT) for anxiety. We also assessed its acceptability among stakeholders....
Autores principales: | Aoki, Yumi, Takaesu, Yoshikazu, Inada, Ken, Yamada, Hiroki, Murao, Tomohiko, Kikuchi, Toshiaki, Takeshima, Masahiro, Tani, Masayuki, Mishima, Kazuo, Otsubo, Tempei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213963/ https://www.ncbi.nlm.nih.gov/pubmed/37252154 http://dx.doi.org/10.3389/fpsyt.2023.1083568 |
Ejemplares similares
-
Does cognitive behavioral therapy for anxiety disorders assist the discontinuation of benzodiazepines among patients with anxiety disorders? A systematic review and meta‐analysis
por: Takeshima, Masahiro, et al.
Publicado: (2021) -
Development and acceptability of a decision aid for chronic insomnia considering discontinuation of benzodiazepine hypnotics
por: Aoki, Yumi, et al.
Publicado: (2021) -
Attitudes and Difficulties Associated with Benzodiazepine Discontinuation
por: Takeshima, Masahiro, et al.
Publicado: (2022) -
A Comparison between Perceptions of Psychiatric Outpatients and Psychiatrists Regarding Benzodiazepine Use and Decision Making for Its Discontinuation: A Cross-Sectional Survey in Japan
por: Aoki, Yumi, et al.
Publicado: (2023) -
Development and acceptability of a decision aid for major depressive disorder considering discontinuation of antidepressant treatment after remission
por: Aoki, Yumi, et al.
Publicado: (2022)